| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.21 | 0.0002 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.21 | 0.0005 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |